hotspot -WSS

hotspot

author：entertainment 2025-09-27 12:56:35 - browse：2224

Perrigo Opill press photo – pharma coverage from STAT — Opill, the first over-the-counter birth control pill, is on its way to U.S. stores. Perrigo via AP

WASHINGTON — The first over-the-counter birth control pill will be available in U.S. stores later this month, allowing American women and teens to purchase contraceptive medication as easily as they buy aspirin.

Manufacturer Perrigo said Monday it has begun shipping the medication, Opill, to major retailers and pharmacies. A one-month supply will cost about $20 and a three-month supply will cost around $50, according to the company’s suggested retail price. It will also be sold online.

The launch has been closely watched since last July, when the Food and Drug Administration said the once-a-day Opill could be sold without a prescription. Ireland-based Perrigo noted there will be no age restrictions on sales, similar to other over-the-counter medications.

Opill is an older class of contraceptive, sometimes called minipills, that contain a single synthetic hormone, progestin, and generally carry fewer side effects than more popular combination estrogen and progestin pills.

Newsletters

Sign up for Morning Rounds

Understand how science, health policy, and medicine shape the world every day

Please enter a valid email address. Privacy Policy

The launch gives U.S. women another birth control option amid the legal and political battles over reproductive health, including the reversal of Roe v. Wade, which has upended abortion access across the U.S. Opill’s approval is unrelated to the ongoing court battles over the abortion pill mifepristone. And anti-abortion groups have generally emphasized that they do not oppose contraceptives to prevent pregnancies.

Birth control pills are available without a prescription across much of South America, Asia, and Africa.

The drug’s approval came despite some concerns by FDA scientists about the company’s results, including whether women with certain medical conditions would understand that they shouldn’t take the drug.

Dr. Verda Hicks, president of the American College of Obstetricians and Gynecologists, in a statement, said studies have shown that patients, including adolescents, can effectively screen themselves to use the pills.

— Matthew Perrone

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Scientists grapple with ethics of stem cell research

hotspot

focus

WSS

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

CDC: Cases of alpha

Stoke drug shows lower activity against childhood epilepsy

'CMA Fest' 2023: How to watch, who is performing and more

The mammogram wars are not over

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

leisure time

hotspot

Sign up for Morning Rounds

hotspot

Drug repurposing or repositioning? The language matters

CDC: Cases of alpha

Medicare proposal to cover medical devices draws a mixed reaction

Judge denies Trump's request for new trial in E. Jean Carroll case

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Interest rates are at a 22

Duchenne breakthrough therapy leaves behind pioneering families

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Activists slam private health insurers over coverage restrictions

The mammogram wars are not over

hotspot

The stock market has soared this year, but will it last? Experts weigh in

VC firm RA Capital starts a new synthetic biology incubator

Mystery swirls around US soldier who entered North Korea days ago, officials say

Stoke drug shows lower activity against childhood epilepsy

Timeline: Special counsel's probe into Trump's handling of classified documents

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

hotspot

hotspot

focus

knowledge